India & Switzerland Explore Investment Opportunities in the Pharmaceutical Sector
Advertisement
The discussions focused on strengthening collaboration in research and innovation, as well as on new investment opportunities for Swiss pharma companies in India's rapidly growing healthcare and life sciences sector.
In a move to strengthen the pharma sector and deepen bilateral economic cooperation, India and Switzerland have held discussions to expand investment opportunities in the pharma sector.
The discussions took place during the recent visit of Union Minister of Commerce and Industry Piyush Goyal to Berne, Switzerland.
The Union Minister co-chaired a meeting with Helene Budliger Artieda, State Secretary for Economic Affairs of Switzerland, and representatives of leading Swiss pharmaceutical and biotechnology companies.
Sharing the details of the discussion in a social media post, Union Minister Piyush Goyal said, “Began my visit to Switzerland by co-chairing a meeting with. Helene Budliger Artieda, State Secretary for Economic Affairs of Switzerland, and representatives of leading Swiss pharmaceutical and biotechnology companies.”
He further stated that discussions focused on strengthening collaboration in research and innovation, as well as on new investment opportunities for Swiss pharma companies in India's rapidly growing healthcare and life sciences sector.
In addition, the Union Minister held a bilateral meeting with Guy Parmelin, President of the Swiss Confederation.
“Our discussions reaffirmed the strong and enduring partnership between India and Switzerland, with a shared commitment to further strengthening economic engagement, investment flows, and strategic cooperation under the India-EFTA Trade and Economic Partnership Agreement (TEPA),” he added.
The latest development follows a high-level meeting between Swiss President Guy Parmelin, Prime Minister Narendra Modi, and Commerce and Industry Minister Piyush Goyal in New Delhi earlier this year.
The delegation focused on integrating biotech, pharmaceutical trade, and responsible AI governance into a unified economic agenda.
The India-European Free Trade Association Trade and Economic Partnership Agreement (TEPA), implemented last year, Switzerland and fellow EFTA members, Iceland, Liechtenstein, and Norway, have opened 92.2% of tariff lines, covering 99.6% of India’s exports.
The agreement is positioned as a gateway for Indian pharmaceutical and biotech products into high-income European markets known for stringent regulatory standards and strong demand for quality healthcare solutions.
Stay tuned for more such updates on Digital Health News
